Mifepristone (RU-486 ® ) as a Schedule IV Controlled Drug-Implications for a Misleading Drug Policy on Women's Health Care.

Yi-Ping HsiehYun-Ju WangLing-Yi FengLi-Tzy Wu Jih-Heng Li

Published in: International journal of environmental research and public health (2022)

Listing mifepristone as a controlled drug could impede the acceptability and accessibility of safe mifepristone use and violates women's right to health care.

Keyphrases

healthcare
polycystic ovary syndrome
public health
pregnancy outcomes
adverse drug
emergency department
pregnant women